The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness.

CONTEXT Critical illness is associated with the low T(3) syndrome. It remains unclear whether altered type II deiodinase activity (D2) in skeletal muscle contributes to this syndrome. OBJECTIVE Our objective was to study D2 expression and activity in skeletal muscle of acute and prolonged critically ill patients. DESIGN AND SETTING We conducted a clinical observational study in acute and prolonged critical illness with comparison with healthy controls at a university hospital surgical intensive care unit. PATIENTS Subjects included 63 prolonged critically ill patients who died in the intensive care unit, 21 acutely ill patients, and 38 controls matched for age, gender, and body mass index. RESULTS Elevated expression of the D2 gene and D2 activity in skeletal muscle of prolonged, but not acute, critically ill patients were observed in the face of low circulating thyroid hormone levels. CONCLUSIONS Reduced D2 activity does not appear to play a role in the pathogenesis of the low T(3) syndrome of critical illness.

[1]  G. Van den Berghe,et al.  Cortisol response to critical illness: effect of intensive insulin therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[2]  J. Harney,et al.  Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. , 2005, The Journal of clinical investigation.

[3]  G. Van den Berghe,et al.  Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.

[4]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[5]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[6]  V. Kyriazopoulou,et al.  Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. , 2001, The Journal of clinical endocrinology and metabolism.

[7]  G. Van den Berghe,et al.  Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone‐secretagogues , 1997, Clinical endocrinology.

[8]  J. Harney,et al.  Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. , 1996, Endocrinology.

[9]  E. Krenning,et al.  The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism , 1993, Clinical endocrinology.

[10]  J L Coolens,et al.  Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. , 1987, Journal of steroid biochemistry.

[11]  K. Burman,et al.  Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". , 1982, Endocrine reviews.

[12]  P. Larsen,et al.  An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. , 1982, Endocrinology.

[13]  P. Moor,et al.  Immunochemical quantitation of human transcortin. , 1974 .